157 related articles for article (PubMed ID: 23715697)
1. Cellular prion protein (PrPC) of the neuron cell transformed to a PK-resistant protein under oxidative stress, comprising main mitochondrial damage in prion diseases.
Yuan F; Yang L; Zhang Z; Wu W; Zhou X; Yin X; Zhao D
J Mol Neurosci; 2013 Sep; 51(1):219-24. PubMed ID: 23715697
[TBL] [Abstract][Full Text] [Related]
2. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
[TBL] [Abstract][Full Text] [Related]
3. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
[TBL] [Abstract][Full Text] [Related]
4. A new mechanism for transmissible prion diseases.
Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Ostapchenko VG; Budka H; Rohwer RG; Baskakov IV
J Neurosci; 2012 May; 32(21):7345-55. PubMed ID: 22623680
[TBL] [Abstract][Full Text] [Related]
5. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
6. Assessing proteinase K resistance of fish prion proteins in a scrapie-infected mouse neuroblastoma cell line.
Salta E; Kanata E; Ouzounis CA; Gilch S; Schätzl H; Sklaviadis T
Viruses; 2014 Nov; 6(11):4398-421. PubMed ID: 25402173
[TBL] [Abstract][Full Text] [Related]
7. Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70).
Mays CE; Armijo E; Morales R; Kramm C; Flores A; Tiwari A; Bian J; Telling GC; Pandita TK; Hunt CR; Soto C
J Biol Chem; 2019 Sep; 294(37):13619-13628. PubMed ID: 31320473
[TBL] [Abstract][Full Text] [Related]
8. Cellular cholesterol enrichment prevents prion peptide-induced neuron cell damages.
Jeong JK; Seol JW; Moon MH; Seo JS; Lee YJ; Kim JS; Park SY
Biochem Biophys Res Commun; 2010 Oct; 401(4):516-20. PubMed ID: 20875400
[TBL] [Abstract][Full Text] [Related]
9. Cellular prion protein neuroprotective function: implications in prion diseases.
Roucou X; LeBlanc AC
J Mol Med (Berl); 2005 Jan; 83(1):3-11. PubMed ID: 15645198
[TBL] [Abstract][Full Text] [Related]
10. Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid.
D'Castro L; Wenborn A; Gros N; Joiner S; Cronier S; Collinge J; Wadsworth JD
PLoS One; 2010 Dec; 5(12):e15679. PubMed ID: 21187933
[TBL] [Abstract][Full Text] [Related]
11. Redox control of prion and disease pathogenesis.
Singh N; Singh A; Das D; Mohan ML
Antioxid Redox Signal; 2010 Jun; 12(11):1271-94. PubMed ID: 19803746
[TBL] [Abstract][Full Text] [Related]
12. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
[TBL] [Abstract][Full Text] [Related]
13. Protein misfolding cyclic amplification induces the conversion of recombinant prion protein to PrP oligomers causing neuronal apoptosis.
Yuan Z; Yang L; Chen B; Zhu T; Hassan MF; Yin X; Zhou X; Zhao D
J Neurochem; 2015 Jun; 133(5):722-9. PubMed ID: 25810062
[TBL] [Abstract][Full Text] [Related]
14. Lithium alleviates neurotoxic prion peptide-induced synaptic damage and neuronal death partially by the upregulation of nuclear target REST and the restoration of Wnt signaling.
Song Z; Yang W; Zhou X; Yang L; Zhao D
Neuropharmacology; 2017 Sep; 123():332-348. PubMed ID: 28545972
[TBL] [Abstract][Full Text] [Related]
15. Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases.
Meneghetti E; Gasperini L; Virgilio T; Moda F; Tagliavini F; Benetti F; Legname G
Mol Neurobiol; 2019 Sep; 56(9):6035-6045. PubMed ID: 30710214
[TBL] [Abstract][Full Text] [Related]
16. REST alleviates neurotoxic prion peptide-induced synaptic abnormalities, neurofibrillary degeneration and neuronal death partially via LRP6-mediated Wnt-β-catenin signaling.
Song Z; Zhu T; Zhou X; Barrow P; Yang W; Cui Y; Yang L; Zhao D
Oncotarget; 2016 Mar; 7(11):12035-52. PubMed ID: 26919115
[TBL] [Abstract][Full Text] [Related]
17. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
[TBL] [Abstract][Full Text] [Related]
18. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
Faburay B; Tark D; Kanthasamy AG; Richt JA
Prion; 2014; 8(6):393-403. PubMed ID: 25495764
[TBL] [Abstract][Full Text] [Related]
19. Translocation of cellular prion protein to non-lipid rafts protects human prion-mediated neuronal damage.
Jeong JK; Moon MH; Lee YJ; Seol JW; Park SY
Int J Mol Med; 2012 Mar; 29(3):387-92. PubMed ID: 22179431
[TBL] [Abstract][Full Text] [Related]
20. Properties and pathogenicity of prion-derived peptides.
Vassallo N
Protein Pept Lett; 2009; 16(3):230-8. PubMed ID: 19275735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
